Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

بواسطة Garg, M, Kanojia, D, Mayakonda, A, Ganesan, T.S, Sadhanandhan, B, Suresh, S, Sneha, S, Nagare, R.P, Said, J.W, Doan, N.B, Ding, L.-W, Baloglu, E, Shacham, S, Kauffman, M, Koeffler, H.P
منشور في 2020